Invion Limited

A$0.03As of Sun 8 Nov 2026, 12:00 UTC
ASX:IVXHealthcare
Country Australia
PE (Fwd) •••
TSR 10Y CAGR (17.61%)
Div yield —
ROE (83.02%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.21
PE TTM —
TSR TTM (63.44%)
Mkt cap A$3.713M
ROIC (46.83%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$0.0361
6.24%
(94.60%)
Hold 7|3|6|8|4
2Q26
3Q26
4Q26
1Q27
Earnings per share$
—
—
—
—
1.87%
7.69%
13.31%
22.88%
Revenue$M
0.305
0.299
0.309
0.313
(0.46%)
(0.97%)
4.73%
8.63%
Peers (US$2.550M)
Cap (US$)
PE
1.616M
—
Capital
TTM
5Y
10Y
Leveragex
0.775
(0.248)
(0.195)
EBIT/Intx
0.737
0.170
0.207
Own earn%
48.29
20.31
7.48
Sh yield%
50.01
35.25
36.29
Owners
Insiders/Inst%
0.12
69.62
Short interest%
5.93
SBC / revenue%
1.41
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
24
Op margin range%
7–16
$1 testx
—
Incr. ROIC%
9